Amplity Medical →

Outsourcing global clinical 
& medical engagement for accelerated drug approval 
& acceptance

Amplity Sales →

Flexible, scalable sales teams for rapid product launch 
& lifecycle management

Amplity Intel →

AnswerY™, an AI-driven, HIPAA-compliant platform of prescriber-patient conversations that drives next-best actions

Amplity Comms →

Premium content & audience access to critical oncology care networks

Amplity Learn →

Continuous growth for teams and individuals led by pharma industry experts

Case Studies

Our Work

Amplity Medical

Nurse Teams Rare Disease

23 of 100 Ultra-Rare Disease Patients Found

April 24, 2025

Intel

Biosimilars

AI Survey Levels Up HCP Outreach

April 18, 2025

Biosimilars

• Intel

AI Survey Levels Up HCP Outreach

April 18, 2025

Intel

Infectious Disease, Oncology

Intel Uncovers Treatment “Whys”

March 20, 2025

Infectious Disease, Oncology

• Intel

Intel Uncovers Treatment “Whys”

March 20, 2025

Intel

Neurology, Rare Disease

AnswerY Delivers 19:1 ROI

January 8, 2025

Neurology, Rare Disease

• Intel

AnswerY Delivers 19:1 ROI

January 8, 2025

Powerful Partnerships Start Here

Amplity Medical →

Amplity Sales →

Amplity Intel →

Amplity Comms →

Amplity Learn →

Who We Are

Leadership

Who We Are

Leadership

Expertise

Our Work

Our News

Careers

Who We Are

Leadership

Expertise

Our Work

Our News

Careers

Case Studies

Our Work

23 of 100 Ultra-Rare Disease Patients Found

April 24, 2025

AI Survey Levels Up HCP Outreach

April 18, 2025

AI Survey Levels Up HCP Outreach

April 18, 2025

Intel Uncovers Treatment “Whys”

March 20, 2025

Intel Uncovers Treatment “Whys”

March 20, 2025

AnswerY Delivers 19:1 ROI

January 8, 2025

AnswerY Delivers 19:1 ROI

January 8, 2025